Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 7/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28969036 | 1.00 | MDM4 (0.46) | MDM4TP53MDM2NPC1RAB9A | |
| SCHEMBL30306804 | 0.92 | MDM4 (0.42) | MDM4TP53MDM2NPC1RAB9A | |
| SCHEMBL28969018 | 0.82 | CSNK2A2 (0.49) | MDM4TP53MDM2CASP3CSNK2A2 | |
| SCHEMBL28969020 | 0.82 | CSNK2A2 (0.49) | MDM4TP53MDM2CASP3CSNK2A2 | |
| SCHEMBL28969016 | 0.82 | MDM4 (0.52) | MDM4TP53MDM2NPC1RAB9A | |
| SCHEMBL28969017 | 0.82 | MDM4 (0.52) | MDM4TP53MDM2NPC1RAB9A | |
| SCHEMBL28968885 | 0.82 | MDM4 (0.40) | MDM4TP53MDM2NPC1RAB9A | |
| SCHEMBL21764273 | 0.77 | MDM4 (0.47) | MDM4TP53MDM2CASP3CASP1 | |
| SCHEMBL29532800 | 0.77 | MDM4 (0.47) | MDM4TP53MDM2CASP3CASP1 | |
| SCHEMBL31080842 | 0.76 | MDM4 (0.44) | MDM4TP53MDM2CASP3CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115666553-A | TLR2 modulator compounds, and pharmaceutical compositions and uses thereof | 轴向治疗公司 | 2023-01-31 | — | — | CN | disclosed |